Global Tendonitis Treatment Market by Condition (Golfer’s Elbow, Tennis Elbow, Swimmer’s Shoulder, Jumper’s Knee, Pitcher’s Elbow) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global tendonitis market was worth USD 190.1 billion in 2020. It is expected to grow at a compound annual rate (CAGR of 2.8%) between 2021 and 2028. Market growth is expected to be driven by tendonitis increasing incidence due to the aging population, sports injuries and occupational injuries, as well as injuries sustained during physical exercise or trauma. Children and teens are more likely to develop tendonitis due to their increased use of electronic devices. According to the Bureau of Labor Statistics, tendonitis can cause more than 70k people to miss work each year. Market growth is impeded by the frequent nature of injuries and side effects.
Due to the rapid rise in sports activities, the number of sports-related soft tissue injuries is on the rise and is a major driver for the market. A growing number of people are choosing sports as a profession or hobby due to the increasing career options and inclination toward healthy fitness. This, in turn, will increase their risk of sustaining injuries. A study by sports medicine professors at Duke University and University of Virginia found that approximately 40% to 50% of competitive runners suffer from Achilles tendinopathy.
Tendonitis treatment will continue to grow due to the increasing prevalence of tendonitis among the general population, which is estimated at 5-10 cases per 100,000 people. The market is also growing due to the increasing availability of treatment options, such as physical therapy and over-the-counter pain medications. Because of its effectiveness in treating various chronic tendon conditions, physical therapy is the best treatment option for tendonitis.
Tendons are a connective tissue with a high alignment that transmits force from bone to muscle. Each year, more than 32.0 million tendon injuries are reported. Tendinopathies account to 50.0% of all sports-related injury. The aging population has led to an increase in tendon injuries over the past decade. The current tendon treatment protocols for clinical grafts are restricted and there is a high demand for engineered tissue. To sustain market growth, there is a strong need for new strategies like tendon regeneration and replacement.
Impact of COVID19 Tendonitis Treatment Market: 3.4% decrease in revenue growth between 2019 and 2020
|
Pandemic Impact |
Outlook after COVID |
|
From 2019 to 2020, the market fell by 3.4% |
Market growth is expected to be between 2.0% and 2.6% each year over the next five-years. |
|
Lack of Personal Protective Equipment (PPE), a shortage in the workforce, and restrictions and lockdowns caused healthcare facilities to reschedule or prioritize essential and non-essential procedures. Many tendonitis treatments and physical therapies were not considered necessary during the pandemic. This can be attributed in part to the decline of market growth. |
Once the pandemic has stabilized, healthcare facilities will be focusing on strategies for restarting elective surgeries like septic disorders or traumatic tendon injuries. The majority of healthcare facilities will also be responsible for managing sudden injuries and delayed tendonitis-related trauma. |
|
Manufacturing, supply chains and product distribution were all affected by the pandemic. Many companies in the market reported a drop in sales of tendonitis treatments. |
Healthcare facilities around the world are currently evaluating the severity of emergencies and are working to forecast the "new normal" and change the priority order for treatment procedures in the post-COVID scenario. This will provide positive growth prospects in the future. |
Key companies have adopted key strategies to gain a competitive advantage in the market, including increased investments in R&D and geographic expansions. Orthocell Limited, a regenerative medicine firm, entered into a research cooperation agreement with DePuy Synthes in January 2017 to promote its OrthoATI stem cell approach for the regeneration of degenerated ligaments.
Treatment Insights
The therapy segment was the dominant market segment for tendonitis treatment in 2020 and accounted for the largest revenue percentage of 73.4%. This is due to patients' increasing preference for non-invasive treatments over surgical tendonitis treatment. Physical therapy was the most popular therapy segment because it is the first line of treatment. Other therapy types such as shockwave therapy and hot and cold therapy have seen significant growth in demand in the last few years.
NSAIDs can also be used as a preliminary treatment for tendinitis. Surgery is the only option for tendonitis treatment in severe cases of damage to the tendons. The first 48 hours after injury, cold therapy (including cold compresses) is most effective. There are many treatment options available for tendonitis. Each type of indication is different. Achilles Tendonitis is the most common type of tendonitis. The Achilles tendon is the largest tendon in the body.
Condition Insights
Due to an increase in athletes and sports players, the Achilles tendonitis market was the dominant segment. According to the NCBI article, "Biomedical Risk Factors for Achilles Tendinopathy In Physically Active People", the cumulative lifetime injury rate for Achilles Tendinopathy is approximately 24.0% among athletes in 2021. It has been reported that Achilles tendinopathy is more common in elite athletes than it is in recreational athletes. There are both surgical and conservative options for Achilles tendonitis. These can be used to treat acute or chronic conditions. Specialists highly recommend surgery for individuals who have suffered a complete rupture.
Due to increasing prevalence of medial and lateral elbow tendinopathy, the golfer's elbow segment will grow the fastest over the forecast period. According to an NCBI article published May 2018 on Golfer’s elbow, golfer’s elbow is most common between 40-60 years old and affects both men and women at the same time. The growing number of geriatrics and the changing lifestyles that lead to more physical and sport activities eventually leads to an increase in elbow tendinopathy.
Regional Insights
Asia Pacific was the dominant market for tendonitis treatments and had the highest revenue share at 69.7% in 2020. This is due to the increasing number of tendonitis procedures performed in the region as well as rising disposable income. The tendonitis market has seen significant growth due to the increasing penetration of local medical device manufacturers and the growing target population. Other key drivers of the market include ongoing research in this area, growing products in the pipeline to treat tendonitis, especially in China and Japan, as well as an increase in sports-related injuries.
Lain America will likely see the fastest CAGR, at 3.3%, during the forecast period. One of the main reasons for market growth is the presence of many hospitals and medical centers in Latin America that perform surgical procedures and tendonitis treatments. Many highly-respected surgeons, physicians, medical experts, and specialists from other countries have teamed up in Latin American regional hospitals to develop cutting-edge treatment protocols that are patient-centric.
Market Share Insights & Key Companies
The tendonitis market has seen a significant increase in the presence of small, but well-established players both domestically and internationally. To expand their product range and increase market reach, most companies have multiple mergers and acquisitions. Orthocell, for example, announced positive results from a study on its Ortho-ATI - a tendon cell therapy treatment that treats tennis elbow. The study was expected to boost the growth of the innovative tendonitis therapy segment, as well as the shoulder and elbow segments. The market leader in tendonitis treatment is:
-
Merck and Co., Inc.
-
AstraZeneca
-
Boehringer Ingelheim Pharmaceuticals, Inc.
-
Abbott
-
Pfizer
-
Bayer AG
-
GlaxoSmithKline PLC
-
Almatica Pharma, Inc.
-
Teva Pharmaceuticals Industries
Up Market Research published a new report titled “Tendonitis Treatment Market research report which is segmented by Condition (Golfer’s Elbow, Tennis Elbow, Swimmer’s Shoulder, Jumper’s Knee, Pitcher’s Elbow), By Players/Companies Bayer AG, Pfizer, AstraZeneca, Abbott, Teva Pharmaceuticals Industries, GlaxoSmithKline PLC, Almatica Pharma Inc, Merck and Co Inc, Boehringer Ingelheim Pharmaceuticals Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Tendonitis Treatment Market Research Report |
| By Condition | Golfer’s Elbow, Tennis Elbow, Swimmer’s Shoulder, Jumper’s Knee, Pitcher’s Elbow |
| By Companies | Bayer AG, Pfizer, AstraZeneca, Abbott, Teva Pharmaceuticals Industries, GlaxoSmithKline PLC, Almatica Pharma Inc, Merck and Co Inc, Boehringer Ingelheim Pharmaceuticals Inc |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 241 |
| Number of Tables & Figures | 169 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Tendonitis Treatment Market Report Segments:
The market is segmented by Condition (Golfer’s Elbow, Tennis Elbow, Swimmer’s Shoulder, Jumper’s Knee, Pitcher’s Elbow).
Tendonitis Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tendonitis Treatment Market
Overview of the regional outlook of the Tendonitis Treatment Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Tendonitis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Tendonitis Treatment Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Golfer’s Elbow
2. Tennis Elbow
3. Swimmer’s Shoulder
4. Jumper’s Knee
5. Pitcher’s Elbow
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tendonitis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Tendonitis Treatment Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tendonitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tendonitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tendonitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tendonitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tendonitis Treatment Market Size & Forecast, 2018-2028
4.5.1 Tendonitis Treatment Market Size and Y-o-Y Growth
4.5.2 Tendonitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Tendonitis Treatment Market Analysis and Forecast by Condition
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Condition
5.1.2 Basis Point Share (BPS) Analysis by Condition
5.1.3 Absolute $ Opportunity Assessment by Condition
5.2 Tendonitis Treatment Market Size Forecast by Condition
5.2.1 Golfer’s Elbow
5.2.2 Tennis Elbow
5.2.3 Swimmer’s Shoulder
5.2.4 Jumper’s Knee
5.2.5 Pitcher’s Elbow
5.3 Market Attractiveness Analysis by Condition
Chapter 6 Global Tendonitis Treatment Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Tendonitis Treatment Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Tendonitis Treatment Analysis and Forecast
8.1 Introduction
8.2 North America Tendonitis Treatment Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Tendonitis Treatment Market Size Forecast by Condition
8.6.1 Golfer’s Elbow
8.6.2 Tennis Elbow
8.6.3 Swimmer’s Shoulder
8.6.4 Jumper’s Knee
8.6.5 Pitcher’s Elbow
8.7 Basis Point Share (BPS) Analysis by Condition
8.8 Absolute $ Opportunity Assessment by Condition
8.9 Market Attractiveness Analysis by Condition
Chapter 9 Europe Tendonitis Treatment Analysis and Forecast
9.1 Introduction
9.2 Europe Tendonitis Treatment Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Tendonitis Treatment Market Size Forecast by Condition
9.6.1 Golfer’s Elbow
9.6.2 Tennis Elbow
9.6.3 Swimmer’s Shoulder
9.6.4 Jumper’s Knee
9.6.5 Pitcher’s Elbow
9.7 Basis Point Share (BPS) Analysis by Condition
9.8 Absolute $ Opportunity Assessment by Condition
9.9 Market Attractiveness Analysis by Condition
Chapter 10 Asia Pacific Tendonitis Treatment Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Tendonitis Treatment Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Tendonitis Treatment Market Size Forecast by Condition
10.6.1 Golfer’s Elbow
10.6.2 Tennis Elbow
10.6.3 Swimmer’s Shoulder
10.6.4 Jumper’s Knee
10.6.5 Pitcher’s Elbow
10.7 Basis Point Share (BPS) Analysis by Condition
10.8 Absolute $ Opportunity Assessment by Condition
10.9 Market Attractiveness Analysis by Condition
Chapter 11 Latin America Tendonitis Treatment Analysis and Forecast
11.1 Introduction
11.2 Latin America Tendonitis Treatment Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Tendonitis Treatment Market Size Forecast by Condition
11.6.1 Golfer’s Elbow
11.6.2 Tennis Elbow
11.6.3 Swimmer’s Shoulder
11.6.4 Jumper’s Knee
11.6.5 Pitcher’s Elbow
11.7 Basis Point Share (BPS) Analysis by Condition
11.8 Absolute $ Opportunity Assessment by Condition
11.9 Market Attractiveness Analysis by Condition
Chapter 12 Middle East & Africa (MEA) Tendonitis Treatment Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Tendonitis Treatment Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Tendonitis Treatment Market Size Forecast by Condition
12.6.1 Golfer’s Elbow
12.6.2 Tennis Elbow
12.6.3 Swimmer’s Shoulder
12.6.4 Jumper’s Knee
12.6.5 Pitcher’s Elbow
12.7 Basis Point Share (BPS) Analysis by Condition
12.8 Absolute $ Opportunity Assessment by Condition
12.9 Market Attractiveness Analysis by Condition
Chapter 13 Competition Landscape
13.1 Tendonitis Treatment Market: Competitive Dashboard
13.2 Global Tendonitis Treatment Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Bayer AG
13.3.2 Pfizer
13.3.3 AstraZeneca
13.3.4 Abbott
13.3.5 Teva Pharmaceuticals Industries
13.3.6 GlaxoSmithKline PLC
13.3.7 Almatica Pharma Inc
13.3.8 Merck and Co Inc
13.3.9 Boehringer Ingelheim Pharmaceuticals Inc
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tendonitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tendonitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tendonitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tendonitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tendonitis Treatment Market Size & Forecast, 2018-2028
4.5.1 Tendonitis Treatment Market Size and Y-o-Y Growth
4.5.2 Tendonitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Tendonitis Treatment Market Analysis and Forecast by Condition
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Condition
5.1.2 Basis Point Share (BPS) Analysis by Condition
5.1.3 Absolute $ Opportunity Assessment by Condition
5.2 Tendonitis Treatment Market Size Forecast by Condition
5.2.1 Golfer’s Elbow
5.2.2 Tennis Elbow
5.2.3 Swimmer’s Shoulder
5.2.4 Jumper’s Knee
5.2.5 Pitcher’s Elbow
5.3 Market Attractiveness Analysis by Condition
Chapter 6 Global Tendonitis Treatment Market Analysis and Forecast by Region
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Region
6.1.2 Basis Point Share (BPS) Analysis by Region
6.1.3 Absolute $ Opportunity Assessment by Region
6.2 Tendonitis Treatment Market Size Forecast by Region
6.2.1 North America
6.2.2 Europe
6.2.3 Asia Pacific
6.2.4 Latin America
6.2.5 Middle East & Africa (MEA)
6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
7.1 Introduction
7.2 Current & Future Impact Analysis
7.3 Economic Impact Analysis
7.4 Government Policies
7.5 Investment Scenario
Chapter 8 North America Tendonitis Treatment Analysis and Forecast
8.1 Introduction
8.2 North America Tendonitis Treatment Market Size Forecast by Country
8.2.1 U.S.
8.2.2 Canada
8.3 Basis Point Share (BPS) Analysis by Country
8.4 Absolute $ Opportunity Assessment by Country
8.5 Market Attractiveness Analysis by Country
8.6 North America Tendonitis Treatment Market Size Forecast by Condition
8.6.1 Golfer’s Elbow
8.6.2 Tennis Elbow
8.6.3 Swimmer’s Shoulder
8.6.4 Jumper’s Knee
8.6.5 Pitcher’s Elbow
8.7 Basis Point Share (BPS) Analysis by Condition
8.8 Absolute $ Opportunity Assessment by Condition
8.9 Market Attractiveness Analysis by Condition
Chapter 9 Europe Tendonitis Treatment Analysis and Forecast
9.1 Introduction
9.2 Europe Tendonitis Treatment Market Size Forecast by Country
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 U.K.
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 Europe Tendonitis Treatment Market Size Forecast by Condition
9.6.1 Golfer’s Elbow
9.6.2 Tennis Elbow
9.6.3 Swimmer’s Shoulder
9.6.4 Jumper’s Knee
9.6.5 Pitcher’s Elbow
9.7 Basis Point Share (BPS) Analysis by Condition
9.8 Absolute $ Opportunity Assessment by Condition
9.9 Market Attractiveness Analysis by Condition
Chapter 10 Asia Pacific Tendonitis Treatment Analysis and Forecast
10.1 Introduction
10.2 Asia Pacific Tendonitis Treatment Market Size Forecast by Country
10.2.1 China
10.2.2 Japan
10.2.3 South Korea
10.2.4 India
10.2.5 Australia
10.2.6 South East Asia (SEA)
10.2.7 Rest of Asia Pacific (APAC)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Asia Pacific Tendonitis Treatment Market Size Forecast by Condition
10.6.1 Golfer’s Elbow
10.6.2 Tennis Elbow
10.6.3 Swimmer’s Shoulder
10.6.4 Jumper’s Knee
10.6.5 Pitcher’s Elbow
10.7 Basis Point Share (BPS) Analysis by Condition
10.8 Absolute $ Opportunity Assessment by Condition
10.9 Market Attractiveness Analysis by Condition
Chapter 11 Latin America Tendonitis Treatment Analysis and Forecast
11.1 Introduction
11.2 Latin America Tendonitis Treatment Market Size Forecast by Country
11.2.1 Brazil
11.2.2 Mexico
11.2.3 Rest of Latin America (LATAM)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Latin America Tendonitis Treatment Market Size Forecast by Condition
11.6.1 Golfer’s Elbow
11.6.2 Tennis Elbow
11.6.3 Swimmer’s Shoulder
11.6.4 Jumper’s Knee
11.6.5 Pitcher’s Elbow
11.7 Basis Point Share (BPS) Analysis by Condition
11.8 Absolute $ Opportunity Assessment by Condition
11.9 Market Attractiveness Analysis by Condition
Chapter 12 Middle East & Africa (MEA) Tendonitis Treatment Analysis and Forecast
12.1 Introduction
12.2 Middle East & Africa (MEA) Tendonitis Treatment Market Size Forecast by Country
12.2.1 Saudi Arabia
12.2.2 South Africa
12.2.3 UAE
12.2.4 Rest of Middle East & Africa (MEA)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Middle East & Africa (MEA) Tendonitis Treatment Market Size Forecast by Condition
12.6.1 Golfer’s Elbow
12.6.2 Tennis Elbow
12.6.3 Swimmer’s Shoulder
12.6.4 Jumper’s Knee
12.6.5 Pitcher’s Elbow
12.7 Basis Point Share (BPS) Analysis by Condition
12.8 Absolute $ Opportunity Assessment by Condition
12.9 Market Attractiveness Analysis by Condition
Chapter 13 Competition Landscape
13.1 Tendonitis Treatment Market: Competitive Dashboard
13.2 Global Tendonitis Treatment Market: Market Share Analysis, 2019
13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
13.3.1 Bayer AG
13.3.2 Pfizer
13.3.3 AstraZeneca
13.3.4 Abbott
13.3.5 Teva Pharmaceuticals Industries
13.3.6 GlaxoSmithKline PLC
13.3.7 Almatica Pharma Inc
13.3.8 Merck and Co Inc
13.3.9 Boehringer Ingelheim Pharmaceuticals Inc
Segments Covered in the Report
The global Tendonitis Treatment market has been segmented based on
By Condition
The global Tendonitis Treatment market has been segmented based on
By Condition
- Golfer’s Elbow
- Tennis Elbow
- Swimmer’s Shoulder
- Jumper’s Knee
- Pitcher’s Elbow
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bayer AG
- Pfizer
- AstraZeneca
- Abbott
- Teva Pharmaceuticals Industries
- GlaxoSmithKline PLC
- Almatica Pharma Inc
- Merck and Co Inc
- Boehringer Ingelheim Pharmaceuticals Inc
Our Clients
Related Reports
Some other reports from this category!
